Palliating symptoms of advanced and metastatic cancers are one of the most common
indications for radiation therapy (RT), and the demand for palliative RT is increasing …

Purpose The aim of this prospective multi-institutional phase 2 study was to investigate
disease control, survival outcomes, and toxicity after thoracic three-dimensional radiation …

Objective: We report our experience in providing palliative radiotherapy (RT) to patients with
head and neck cancers (HNCs). Our hypofractionated regimen,“0-7-21”, treats patients with …

Background The healthcare costs of cancer care are highest in the last month of life. The
effect of hospice care on end-of-life (EOL) healthcare costs is not clearly understood …

Purpose A subset of patients with minimal extrathoracic disease may benefit from
aggressive primary tumor treatment. We report comparative outcomes in oligometastatic non …

Background: High-level evidence has established well-recognized standard treatment
regimens for patients undergoing palliative chest radiotherapy (RT) for stage IV non–small …

Context Patients with metastatic non-small cell lung cancer (NSCLC) have limited survival.
Population studies have evaluated the impact of radiation refusal in the curative setting; …

Objective The evaluation of efficacy of palliative thoracic radiotherapy (PTR) in patients with
advanced non-small cell lung cancer (NSCLC) and to compare it with efficacy of supportive …

Introduction: Stage iii lung cancer is the most advanced stage of lung cancer for which
radical (potentially curative) treatment is often discussed. Understanding the reasons for …

Purpose To analyze indications for early palliative radiation therapy (RT)(ie, start within 1
month from cancer diagnosis), regimens used in clinical practice, rate of treatment …